Related Experiment Videos
[Stratification of patients with hypertension and selection of antihypertensive therapy]
Insights
This study shows risk-stratified management effectively treats hypertension. Tailored interventions improved blood pressure, metabolic health, and kidney function in diverse patient groups.
Area of Science:
- Cardiology
- Metabolic Disorders
- Nephrology
Background:
- Hypertension is a global health concern with varying cardiovascular complication risks.
- Effective management requires personalized strategies based on patient risk factors.
Purpose of the Study:
- To evaluate the efficacy of risk stratification in managing patients with hypertension.
- To assess the impact of tailored interventions on cardiovascular risk factors and organ function.
Main Methods:
- Patients were stratified into low, medium, high, and very high cardiovascular risk groups.
- Interventions included lifestyle modifications, antihypertensive medications (ACE inhibitors, calcium antagonists), and hypoglycemic drugs.
- Therapeutic approaches were individualized based on risk stratification and comorbidities like dyslipidemia, obesity, metabolic syndrome, diabetes, and proteinuria.
Main Results:
- Risk stratification-based management led to significant blood pressure normalization.
- Improvements were observed in carbohydrate and lipid metabolism, insulin resistance, and body mass.
- Renal function was notably enhanced in patients receiving complex therapy.
Conclusions:
- Personalized, risk-stratified management is a highly effective strategy for hypertension.
- This approach yields comprehensive benefits beyond blood pressure control, addressing metabolic and renal health.
- Tailored interventions offer a promising pathway for improving overall patient outcomes in hypertension care.
Abstract:
Patients with hypertension (78 men, 113 women aged 20-73 years) were stratified according to risk of development of cardiovascular complications. In low and moderate risk patients (n=31) with borderline hypertension, dyslipidemia and pronounced obesity mainly non-drug measures were employed directed at lowering of excess body mass. Medium risk patients (n=25) with isolated hypertension group were treated with angiotensin converting enzyme inhibitors and phenylalkylamine calcium antagonists. High risk patients (n=55) with metabolic syndrome received same antihypertensive drugs as medium risk patients. In very high risk patients (n=79) with diabetes, excessive body mass, dyslipidemia and proteinuria complex therapy consisting of antihypertensive and hypoglycemic drugs and non-drug interventions was used. This risk stratification based management of patients with hypertension on turned out to be highly effective and resulted not only in normalization of blood pressure but also in improvement of carbohydrate and lipid metabolism, lowering of resistance to insulin and excessive body mass, and improvement of renal function.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure